Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Wilson (1987)
Methods for the economic evaluation of health care programmesJournal of Epidemiology and Community Health, 41
C. Myers, D. Wilks (2004)
Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndromeQuality of Life Research, 8
(2000)
Targeted tuberculin testing and treatment of latent tuberculosis infectionAm J Respir Cri Care Med, 161
(2001)
Global Tuberculosis Control
P. Dorman, M. Dennis, P. Sandercock (1999)
How do scores on the EuroQol relate to scores on the SF-36 after stroke?Stroke, 30 10
J. Ware (2003)
SF-36 health survey: Manual and interpretation guide
D. Enarson (1988)
Isoniazid for the tuberculin reactor: take it or leave.The American review of respiratory disease, 137 6
K. Dasgupta, K. Schwartzman, R. Marchand, Terry Tennenbaum, P. Brassard, D. Menzies (2000)
Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.American journal of respiratory and critical care medicine, 162 6
R. Brooks (1996)
EuroQol: the current state of play.Health policy, 37 1
E. Baráth, B. Rosner (1992)
Fundamentals of Biostatistics.Biometrics, 48
(2000)
Canadian Tuberculosis Standards
G. Anglin (1944)
Tuberculosis in CanadaChest, 10
(1990)
A new facility for the measurement of health-related quality of lifeHealth Policy, 16
W. Chie, Chiun-Sheng Huang, Jen-Hau Chen, K. Chang (1999)
Measurement of the quality of life during different clinical phases of breast cancer.Journal of the Formosan Medical Association = Taiwan yi zhi, 98 4
J. Landis, G. Koch (1977)
The measurement of observer agreement for categorical data.Biometrics, 33 1
C. Jenkins (1992)
Assessment of outcomes of health intervention.Social science & medicine, 35 4
A. Donner, M. Eliasziw (1987)
Sample size requirements for reliability studies.Statistics in medicine, 6 4
Kramer, A. Feinstein (1981)
THE BIOSTATISTICS OF CONCORDANCE, 29
J. Fitzgerald, A. Gafni (1990)
A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test.The American review of respiratory disease, 142 4
A. Wagner, B. Gandek, N. Aaronson, C. Acquadro, J. Alonso, Giovanni Apolone, Monika Bullinger, J. Bjorner, Shunichi Fukuhara, S. Kaasa, A. Leplège, M. Sullivan, S. Wood-Dauphinee, J. Ware (1998)
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment.Journal of clinical epidemiology, 51 11
P. Dorman, J. Slattery, B. Farrell, M. Dennis, P. Sandercock (1998)
Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial.Stroke, 29 1
J. Ware (1994)
SF-36 physical and mental health summary scales : a user's manual
R. Arocho, C. McMillan, P. Sutton-Wallace (1998)
Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasiaQuality of Life Research, 7
D. Beaton, S. Hogg-Johnson, C. Bombardier (1997)
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders.Journal of clinical epidemiology, 50 1
Ray Robinson (1993)
Cost-effectiveness analysis.British Medical Journal, 307
(1997)
Calibrating the ED-5D for a Canadian population
DL Streiner, GR. Norman (1995)
A Practical Guide to Their Developement and Use
M. Dion, P. Tousignant, J. Bourbeau, D. Menzies, K. Schwartzman (2002)
Measurement of Health Preferences among Patients with Tuberculous Infection and DiseaseMedical Decision Making, 22
W. Hopman, T. Towheed, T. Anastassiades, A. Tenenhouse, S. Poliquin, C. Berger, L. Joseph, Jacques Brown, T. Murray, J. Adachi, D. Hanley, E. Papadimitropoulos (2000)
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 163 3
B. Vissandjée, Sophie Dupéré (2000)
Culture, migration et instrument de mesure: défis incontournablesJournal of International Migration and Integration / Revue de l'integration et de la migration internationale, 1
H. Blumberg, W. Burman, R. Chaisson, C. Daley, S. Etkind, L. Friedman, P. Fujiwara, M. Grzemska, P. Hopewell, M. Iseman, R. Jasmer, V. Koppaka, R. Menzies, R. O'brien, R. Reves, L. Reichman, P. Simone, J. Starke, A. Vernon (2003)
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.American journal of respiratory and critical care medicine, 167 4
A. Williams (1990)
EuroQol : a new facility for the measurement of health-related quality of lifeHealth Policy, 16
Doris Chang, Chi Chun, David Takeuchi, Haikang Shen (2000)
SF-36 health survey: tests of data quality, scaling assumptions, and reliability in a community sample of Chinese Americans.Medical care, 38 5
C. Bouchet, Francis Guillemin, A. Paul-Dauphin, S. Briançon (2000)
Selection of quality-of-life measures for a prevention trial: a psychometric analysis.Controlled clinical trials, 21 1
S. Salpeter, G. Sanders, E. Salpeter, D. Owens (1997)
Monitored Isoniazid Prophylaxis for Low-Risk Tuberculin Reactors Older Than 35 Years of Age: A Risk-Benefit and Cost-Effectiveness AnalysisAnnals of Internal Medicine, 127
NE. Mayo, M Goldberg, P. Kind (1998)
Proceedings from EuroQol Plenary Meeting Rotterdam 1997
K. Schwartzman, D. Menzies (2000)
Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.American journal of respiratory and critical care medicine, 161 3 Pt 1
H Njoo, P Nault, M. Phypers (2001)
Tuberculosis in Canada, 1998
J. Thumboo, K. Fong, T. Ng, K. Leong, P. Feng, S. Thio, M. Boey (1999)
Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore.The Journal of rheumatology, 26 1
D. Streiner, G. Norman (1989)
Health Measurement Scales: A practical guide to thier development and use
(2001)
The Tuberculosis Trials Consortium: A model for clinical trials collaborationsPublic Health Reports, 116
WM Hopman, T Towheed, T Anastassiades (2000)
Canadian normative data for the SF-36 health surveyCMAJ, 163
M. Fransen, J. Edmonds (1999)
Reliability and validity of the EuroQol in patients with osteoarthritis of the knee.Rheumatology, 38 9
E. Sumartojo (1993)
When tuberculosis treatment fails. A social behavioral account of patient adherence.The American review of respiratory disease, 147 5
P. Rivest, Terry Tannenbaum, Lucie Bédard (1998)
Epidemiology of tuberculosis in Montreal.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 158 5
P. Kind, P. Dolan, C. Gudex, Alan Williams (1998)
Variations in population health status: results from a United Kingdom national questionnaire surveyBMJ, 316
P. Dorman, J. Slattery, Barbara Farrell, M. Dennis, P. Sandercock (1997)
A randomised comparison of the EuroQol and Short Form-36 after strokeBMJ, 315
L. Geiter, Disease Prevention (2000)
Ending Neglect: The Elimination of Tuberculosis in the United States
M. Kramer, A. Feinstein (1981)
Clinical biostatistics: LIV. The biostatistics of concordanceClinical Pharmacology & Therapeutics, 29
Dauphinee Sw, L. Gauthier, B. Gandek, L. Magnan, U. Pierre (1997)
Readying a US measure of health status, the SF-36, for use in Canada.Clinical and investigative medicine. Medecine clinique et experimentale, 20 4
The dramatic global impact of tuberculosis on mortality has been well documented, but its impact on morbidity has not been well described. The emphasis on treatment of latent tuberculosis (TB) infection highlights the tradeoff between short-term decrements in health status from ‘preventive’ therapy, and long-term gains related to fewer cases of active TB. However, these changes in health status have not been characterized. As a first step, we examined the feasibility and reliability of administering two health status questionnaires, in a multicultural TB clinic setting. The Medical Outcomes Study SF-36 and the EuroQOL EQ-5D were self-administered during 3 weekly interviews. One hundred and eighty-six potentially eligible patients were identified, of whom 112 could be evaluated; 106 (57%) were confirmed eligible. Sixty-seven (63%) agreed to participate; 24 (36%) were women. Fifty-three participants (79%) were foreign-born, with median residence in Canada of 3.5 years. Fifty (75%) of the participants completed all study measurements: 25 were treated for latent TB, 17 for active TB, and eight had previous active TB. Cronbach's α coefficients ranged from 0.73 to 0.94 for the SF-36 domain scores. Intraclass correlation coefficients were 0.66 for the SF-36 physical component summary, 0.79 for the mental component summary, and 0.73 for the EQ-5D. These instruments appeared reliable in a highly selected group of TB patients.
Quality of Life Research – Springer Journals
Published: Oct 18, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.